Western blotting and immunohistochemical experiments have indicated that TNXB is overexpressed in patients with gastric adenocarcinoma with lymph node metastasis (71), which is linked to a lower survival rate in these patients and can serve as a prognostic marker. This evidence concerns the gene TNXB and metastatic malignant neoplasm in the lymph nodes.